aibioSTE STERIS plc
STERIS (STE) news
STERIS plc is a public biotech or pharmaceutical company listed on NYSE under the ticker STE, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest STERIS news
We have not published a story on STERIS yet. When there is news, it will appear here.
What STERIS does
STERIS is a global provider of products and services that support patient care, with an emphasis on infection prevention. It sells consumables such as detergents, endoscopy accessories and barrier products, services such as equipment maintenance and outsourced instrument reprocessing, capital equipment such as sterilizers, surgical tables and automated endoscope reprocessors, and connectivity solutions including operating room integration. The company reports three segments. Healthcare serves sterile processing departments and procedural centers. Applied Sterilization Technologies provides contract sterilization and laboratory testing for medical device and pharmaceutical manufacturers. Life Sciences supports biopharmaceutical and medical device facilities focused on aseptic manufacturing, with products such as pharmaceutical detergents and vaporized hydrogen peroxide room decontamination systems. Its Dental segment was divested in fiscal 2025 and is presented as discontinued operations. Named competitors include 3M, Baxter, Boston Scientific, Ecolab, Stryker and Sterigenics.
| Product or program | What it is | Stage |
|---|---|---|
| Automated endoscope reprocessing systems | Reprocessing and tracking systems for endoscopes | |
| Sterilizers and washers | Capital equipment for sterile processing departments | |
| Surgical tables | Equipment used in procedure rooms | |
| Contract sterilization services | Sterilization and laboratory testing for device and pharmaceutical manufacturers | |
| Vaporized hydrogen peroxide room decontamination systems | Life Sciences decontamination systems |
STERIS annual financials
| Line | FY ended Mar 31, 2026 | FY ended Mar 31, 2025 |
|---|---|---|
| Revenue | $5.94 billion | $5.46 billion |
| Research and development | $112.9 million | $107.6 million |
| Net income (loss) | $782.3 million | $614.6 million |
| Cash from operations | $1.34 billion | $1.15 billion |
| Cash and equivalents | $439.6 million | $171.7 million |
Questions about STERIS
What is the ticker symbol of STERIS?
STERIS plc trades under the ticker STE on NYSE.
Where is STERIS listed?
STERIS plc is listed on NYSE.
Which country or territory is STERIS listed under?
Our directory records STERIS plc under United States.
Does aibio.space cover STERIS?
aibio.space lists STERIS plc among 2,820 public biotech companies and publishes its news here as stories appear.
What does STERIS develop?
STERIS is a global provider of products and services that support patient care, with an emphasis on infection prevention. It sells consumables such as detergents, endoscopy accessories and barrier products, services such as equipment maintenance and outsourced instrument reprocessing, capital equipment such as sterilizers, surgical tables and automated endoscope reprocessors, and connectivity solutions including operating room integration.
What is Automated endoscope reprocessing systems from STERIS?
Automated endoscope reprocessing systems: Reprocessing and tracking systems for endoscopes
What is Sterilizers and washers from STERIS?
Sterilizers and washers: Capital equipment for sterile processing departments
What was STERIS's revenue last year?
$5.94 billion for the fiscal year ended Mar 31, 2026, as reported to the SEC.
Is STERIS profitable?
STERIS plc reported net income of $782.3 million for the fiscal year ended Mar 31, 2026, and generated $1.34 billion of cash from operations, per its annual report to the SEC.
How much does STERIS spend on research and development?
$112.9 million in the fiscal year ended Mar 31, 2026, per its annual report.
How much cash does STERIS have?
$482.3 million in cash at Jun 30, 2026, per its 10-Q.
Investor discussion: STERIS
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Distress
Reported a restructuring, a workforce reduction or a review of strategic alternatives. SEC Form 8-K (Items 2.02,2.05,9.01). Source
Stock chart
Listing details
- Company
- STERIS plc
- Ticker
- STE
- Listing
- NYSE
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction